Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

Re: Does Rexulti affect less receptors then Abilify?

Posted by SLS on May 1, 2016, at 16:23:52

In reply to Re: Does Rexulti affect less receptors then Abilify? » revv33, posted by J Kelly on May 1, 2016, at 12:44:54

Rexulti (brexpiprazole) is less of a D3 dopamine partial receptor agonist than is Abilify. If I understand correctly, there should be less akathisia associated with its use. Rexulti is more active at serotonin 5-HT1a receptors than is Abilify. In addition, Rexulti blocks certain norepinephrine alpha-2 receptors. I don't know what the end result would be of these actions. I guess Rexulti acts as a sort of dopamine-serotonin system modulator.


- Scott


Some see things as they are and ask why.
I dream of things that never were and ask why not.

- George Bernard Shaw

 

Thread

 

Post a new follow-up

Your message only Include above post


[1088600]

Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.

 

Start a new thread

 
Google
dr-bob.org www
Search options and examples
[amazon] for
in

This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:SLS thread:1088590
URL: http://www.dr-bob.org/babble/20160501/msgs/1088600.html